ACE2 and COVID-19: Evidence suggests that current cigarette smokers are at an increased risk of COVID-19 outcomes due to enhanced expression of angiotensin-converting enzyme-2 (ACE-2), which is the gene encoding the receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), throughout the human airway tract [7].